Development of a Rabbit Model for a Preclinical Comparison of Coronary Stent Types In-Vivo |
Lee, Joo Myung
(Innovative Research Institute for Cell Therapy, Seoul National University Hospital)
Lee, Jaewon (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Jeong, Heewon (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Choe, Won Seok (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Seo, Won-Woo (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Lim, Woo-Hyun (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Kim, Young-Chan (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Hur, Jin (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Lee, Sang Eun (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Yang, Han-Mo (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Cho, Hyun-Jai (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) Kim, Hyo-Soo (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) |
1 | Lee JM, Choe W, Kim BK, et al. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials 2012;33:8917-27. DOI ScienceOn |
2 | Van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997;95:438-48. DOI ScienceOn |
3 | Bayes-Genis A, Kantor B, Keelan PC, et al. Restenosis and hyperplasia: Animal Models. Curr Interv Cardiol Rep 2000;2:303-8. |
4 | Perkins LE. Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems. Vet Pathol 2010;47:58-76. DOI ScienceOn |
5 | Asada Y, Kisanuki A, Tsuneyoshi A, Marutsuka K, Hatakeyama K, Sumiyoshi A. Effects of inflation pressure of balloon catheter on vascular injuries and subsequent development of intimal hyperplasia in rabbit aorta. Atherosclerosis 1996;121:45-53. DOI ScienceOn |
6 | Lowe HC, Schwartz RS, Mac Neill BD, et al. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 2003;60:515-23. DOI ScienceOn |
7 | Robert R, Rioufol G, Finet G, et al. Experimental assessment of new stent technologies: validation of a comparative paired rabbit iliac artery study model. J Biomed Mater Res B Appl Biomater 2004;70:303-10. |
8 | Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004;44:1373-85. |
9 | Nakamura T, Winsor-Hines D, Yin X, et al. Vasomotor function and reendothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a timecourse study. EuroIntervention 2012;8:493-500. DOI ScienceOn |
10 | Nakazawa G, Nakano M, Otsuka F, et al. Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis. Circ Cardiovasc Interv 2011;4:38-46. DOI ScienceOn |
11 | Doerning BJ, Brammer DW, Chrisp CE, Rush HG. Nephrotoxicity of tiletamine in New Zealand white rabbits. Lab Anim Sci 1992;42:267-9. |
12 | Robertson SA, Eberhart S. Efficacy of the intranasal route for administration of anesthetic agents to adult rabbits. Lab Anim Sci 1994;44: 159-65. |
13 | Cho HJ, Kim HS, Lee MM, et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003;108:2918-25. DOI ScienceOn |
14 | Van Dyck CJ, Hoymans VY, Bult H, et al. Resolute and Xience V polymerbased drug-eluting stents compared in an atherosclerotic rabbit double injury model. Catheter Cardiovasc Interv 2013;81:E259-68. DOI ScienceOn |
15 | Sommer CM, Grenacher L, Stampfl U, et al. Impact of stent design on in-stent stenosis in a rabbit iliac artery model. Cardiovasc Intervent Radiol 2010;33:565-75. DOI |
16 | Che HL, Bae IH, Lim KS, et al. Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model. Biomaterials 2012;33:8548-56. DOI ScienceOn |
17 | Lim WH, Seo WW, Choe W, et al. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thromb Vasc Biol 2011;31:2798-805. DOI ScienceOn |
18 | Simsek C, Serruys PW. Developments in coronary artery stenting: primum non nocere. Panminerva Med 2011;53:19-30. |
19 | Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501. DOI ScienceOn |
20 | Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (benestent II). Lancet 1998; 352:673-81. DOI ScienceOn |
21 | Cook S, Ladich E, Nakazawa G, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-9. DOI ScienceOn |
22 | Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimusor paclitaxel-eluting stents. Circulation 2005;112:270-8. DOI ScienceOn |
23 | Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001. DOI ScienceOn |
24 | Carter AJ, Aggarwal M, Kopia GA, et al. Long-term effects of polymerbased, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004;63:617-24. DOI ScienceOn |
25 | Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006;354:483-95. DOI ScienceOn |
26 | Akin I, Schneider H, Ince H, et al. Second- and third-generation drugeluting coronary stents: progress and safety. Herz 2011;36:190-6. DOI |
27 | Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol 2010;56(10 suppl):S43-78. DOI ScienceOn |
28 | Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9. DOI ScienceOn |
29 | Touchard AG, Schwartz RS. Preclinical restenosis models: challenges and successes. Toxicol Pathol 2006;34:11-8. DOI ScienceOn |
![]() |